Mitsuru Momose

Mitsuru Momose

Auto-generated profile, based on publicly available information

Mitsuru Momose

Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2009 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
MMMitsuru Momose
Mitsuru Momose
TBTetsuya Babazono
Tetsuya Babazono
CKChisato Kondo
Chisato Kondo
HKHideki Kobayashi
Hideki Kobayashi
TNTakatomo Nakajima
Takatomo Nakajima
KKKiyoko Kusakabe
Kiyoko Kusakabe

3 April 2010 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
YKYukishige Kyoto
Yukishige Kyoto
MMMitsuru Momose
Mitsuru Momose
CKChisato Kondo
Chisato Kondo
MIMichio Itabashi
Michio Itabashi
SKShingo Kameoka
Shingo Kameoka
KKKiyoko Kusakabe
Kiyoko Kusakabe

1 January 2015 in Circulation Journal
Verified
Journal Article
Open access
PDF file
MMMitsuru Momose
Mitsuru Momose
KFKenji Fukushima
Kenji Fukushima
CKChisato Kondo
Chisato Kondo
NSNaoki Serizawa
Naoki Serizawa
ASAtsushi Suzuki
Atsushi Suzuki
SSShuji Sakai
Shuji Sakai
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

22 September 2017 in Annals of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
KNKenichi Nakajima
Kenichi Nakajima
KOKoichi Okuda
Koichi Okuda
MMMitsuru Momose
Mitsuru Momose
SMShinro Matsuo
Shinro Matsuo
CKChisato Kondo
Chisato Kondo
AVA. Hans Vija
A. Hans Vija
IQ·SPECT (Siemens Medical Solutions) is a solution for high-sensitivity and short-time acquisition imaging of the heart for a variable angle general purpose gamma camera. It consists of a multi-focal collimator, a cardio-centric orbit and advanced iterative reconstruction, modeling the image formation physics accurately. The multi-focal collimator enables distance-dependent enlargement of the center region while avoiding truncation at the edges. With the specified configuration and a cardio-centric orbit it can obtain a fourfold sensitivity increase for the heart at the center of the scan orbit. Since IQ·SPECT shows characteristic distribution patterns in the myocardium, appropriate acquisition and processing conditions are required, and normal databases are convenient for quantification of both normal and abnormal perfusion images. The use of prone imaging can be a good option when X-ray computed tomography (CT) is not available for attenuation correction. CT-based attenuation correction changes count distribution significantly in the inferior wall and around the apex, hence image interpretation training and additional use of normal databases are recommended. Recent reports regarding its technology, Japanese Society of Nuclear Medicine working group activities, and clinical studies using 201Tl and 99mTc-perfusion tracers in Japan are summarized.

1 September 2018 in International Journal of Cardiology
Verified
Journal Article
Open access
MNMamoru Nanasato
Mamoru Nanasato
NMNaoya Matsumoto
Naoya Matsumoto
KNKenichi Nakajima
Kenichi Nakajima
TCTaishiro Chikamori
Taishiro Chikamori
MMMasao Moroi
Masao Moroi
TNTsunehiko Nishimura
Tsunehiko Nishimura
Whether myocardial ischemia identified using myocardial perfusion imaging (MPI) can be an alternative target of coronary revascularization to reduce the incidence of cardiac events remains unclear. This multicenter, prospective cohort study aimed to clarify the prognostic impact of reducing myocardial ischemia. Among 494 registered patients with possible or definite coronary artery disease (CAD), 298 underwent initial pharmacological stress 99mTc-tetrofosmin MPI before, and eight months after revascularization or medical therapy, and were followed up for at least one year. Among these, 114 with at least 5% ischemia at initial MPI were investigated. The primary endpoints were cardiac death, non-fatal myocardial infarction and hospitalization for heart failure. Ischemia was reduced ≥5% in 92 patients. Coronary revascularization reduced ischemia (n = 89) more effectively than medical therapy (n = 25). Post-stress cardiac function also improved after coronary revascularization. Ejection fraction significantly improved at stress (61.0% ± 10.7% vs. 65.4% ± 11.3%; p < 0.001) but not at rest (67.1% ± 11.3% vs. 68.3% ± 11.6%; p = 0.144), among patients who underwent revascularization. Rates of coronary revascularization and cardiac events among the 114 patients were significantly higher (13.6%, p = 0.035) and lower (1.1% p = 0.0053), respectively, in patients with, than without ≥5% ischemia reduction. Moreover, patients with complete resolution of ischemia at the time of the second MPI had a significantly better prognosis. Reducing ischemia by ≥5% and the complete resolution of ischemia could improve the prognosis of patients with stable CAD.

17 February 2009 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
MMMitsuru Momose
Mitsuru Momose
KNKenichi Nakajima
Kenichi Nakajima
TNTsunehiko Nishimura
Tsunehiko Nishimura